HSR&D Research Career Scientist Award

高铁

• 批准号: 9769457
• 负责人: MARK A. ILGEN
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9769457
• 关键词: Address; Adverse event; Alcohols; Area; Award; Budgets; Caring; Clinical; Clinical Management; Collaborations; Communities; Databases; Department of Defense; Development; Doctor of Philosophy; Epidemiologist; Evaluation; Family; Funding; Future; Grant; Health; Health Personnel; Health Services; Health Services Research; Homelessness; Improve Access; Institution; International; Intervention; Lead; Leadership; Link; Medical; Mental Health; Mentors; Mentorship; Methods; National Institute of Drug Abuse; Opioid; Outcome; Overdose; Pain; Pain management; Patients; Peer Review; Pharmaceutical Preparations; Physicians; Positioning Attribute; Program Evaluation; Psychologist; Publications; Publishing; Research; Research Design; Research Personnel; Resources; Risk; Risk Factors; Role; Safety; Scientist; Services; Structure; Substance Use Disorder; Suicide; Suicide prevention; System; Testing; Training; Treatment outcome; United States National Institutes of Health; Veterans; Work; addiction; adverse event risk; behavioral health; brief intervention; career; chronic pain; clinical center; comorbidity; design; evidence base; health administration; high risk; improved; innovation; member; next generation; opioid epidemic; randomized trial; research and development; severe mental illness; suicidal risk; telehealth

Substance Use Disorders (SUDs) are common in Veterans Health Administration (VHA) patients and are closely linked to some of the most pressing problems facing Veterans including overdose, suicide risk and homelessness. The VHA is a national leader in providing access to high-quality SUD treatment as well as the development of an evidence-base to inform and improve care for Veterans with SUDs. However, key gaps remain, particularly for Veterans who have co-occurring SUDs and psychiatric and/or medical conditions. Nonetheless, there is the clear potential to expand the positive impact of substance- oriented services within the VA by improving access to behavioral health treatments and integrating these services into addictions treatment. Mark Ilgen, Ph.D. has developed a research portfolio focused on tailoring SUD treatment to address patient comorbidity by conducting Veteran-centric health services research on addiction. The two primary thematic aims of this work are: Aim 1: to improve treatment outcomes and reduce risk of adverse events among Veterans with co-occurring SUDs and chronic pain; and, Aim 2: to decrease the risk of suicide among Veterans with SUDs. These two thematic areas directly relate to positive treatment outcomes, as well as reducing the likelihood of adverse events, among Veterans with SUDs. Dr. Ilgen's contributions to these areas are evidenced by his grant-funded research with support from the VA Health Services Research and Development (HSR&D), the Department of Defense and the National Institute on Drug Abuse, in addition to over 165 peer-reviewed scientific publications. Dr. Ilgen has actively mentored nine early career investigators and/or trainees within the VA and has held key administrative positions within the Ann Arbor VA Center of Innovation (COIN), as a member of the leadership team and the co-lead of the Mentorship Core. Given his active and productive research portfolio, as well as his demonstrated commitment to mentoring colleagues in developing VA research careers, Dr. Ilgen is a strong candidate for a Health Services Research Career Scientist Award. The proposed Research Career Scientist Award will support his continued research, as well an expanded role in mentorship and training of the next generation of HSR&D researchers. This research portfolio has the potential to address some of the most-critical and vexing behavioral health-related priorities in VHA and improve care for some of the most challenging and highest-risk Veterans treated within the VHA system.

药物使用障碍（SUD）在退伍军人卫生管理（VHA）患者中很常见， 与退伍军人面临的一些最紧迫的问题密切相关，包括过量，自杀风险 和无家可归。 VHA是提供获得高质量SUD治疗的国家领导者 以及开发循证基础，以告知和改善对泡沫的退伍军人的护理。 但是，仍然存在关键差距，尤其是对于具有同时发生的泡沫和精神病和/或的退伍军人而言 医疗状况。尽管如此，仍然有明显的潜力扩大物质的积极影响 - 通过改善对行为健康治疗的访问并将其整合来，在VA内定向服务 为成瘾治疗提供服务。马克·伊尔根（Mark Ilgen）博士已经开发了一个研究组合，重点是 调整SUD治疗以通过以资深人士为中心的卫生服务来解决患者合并症 成瘾研究。这项工作的两个主要主题目标是：目标1：改善治疗 结局并降低患有同时发生的泡沫和慢性疼痛的退伍军人之间发生不良事件的风险； 并且，目标2：降低有泡沫的退伍军人中自杀的风险。这两个主题领域直接 与阳性治疗结果以及减少不良事件的可能性有关 有泡沫的退伍军人。伊尔根（Ilgen）博士对这些领域的贡献得到了赠款资助的研究证明 在VA卫生服务研究与发展（HSR＆D）的支持下 国防和美国国家药物滥用研究所，除了经过165次同行评审科学审查之外 出版物。伊尔根（Ilgen）博士积极指导了弗吉尼亚州的九名早期职业调查员和/或学员 并在Ann Arbor VA创新中心（Coin）担任关键行政职务， 领导团队的成员和指导核心的共同领导。鉴于他的积极和富有成效的 研究组合，以及他对开发VA的指导同事表示承诺 研究职业，伊尔根（Ilgen）博士是卫生服务研究职业科学家奖的有力候选人。 拟议的研究职业科学家奖将支持他的持续研究，以及扩展 在下一代HSR＆D研究人员的指导和培训中的角色。该研究组合有 解决VHA中一些与行为健康相关的一些最关键和最困难的行为优先事项的潜力 并改善对VHA中一些最具挑战性和最高风险的退伍军人的护理 系统。